Literature DB >> 9041987

Sleep-related myocardial ischemia and sleep structure in patients with obstructive sleep apnea and coronary heart disease.

H Schäfer1, U Koehler, T Ploch, J H Peter.   

Abstract

STUDY
OBJECTIVES: Patients with coronary heart disease (CHD) and obstructive sleep apnea may have an increased cardiac risk due to nocturnal myocardial ischemia triggered by apnea-associated oxygen desaturation. Sleep structure in patients with obstructive sleep apnea is fragmented by activation of the central nervous system (CNS) (arousal) due to obstructive apneas. Nocturnal myocardial ischemia may lead to activation of the CNS as well. PATIENTS: Fourteen patients with obstructive sleep apnea and CHD disease and seven patients suffering from obstructive sleep apnea without CHD were studied. Overnight sleep studies and simultaneous six-lead ECG recordings were performed. In addition, sleep studies and ECG recordings were performed with administration of a sustained-release nitrate in these patients in a double-blinded crossover design.
RESULTS: Analysis of three nights' recordings revealed 144 episodes of nocturnal myocardial ischemia in six subjects. Five patients had underlying CHD and one patient exhibited diffuse wall defects of the coronary arteries; also, 85.4% of ischemic episodes were concomitant with apneas and oxygen desaturation > 3%, and 77.8% of ischemic episodes occurred during rapid eye movement (REM) sleep, although total amount of REM sleep was only 18% of total sleep time. Mean oxygen saturation was significantly lower (p < 0.05) during apnea-associated ischemic episodes than during nonapnea-associated ischemia (77.3% vs 93.1%). Nitrate administration did not reduce ischemic episodes. Sleep architecture (macrostructure) exhibited a reduction in sleep stages non-REM 3 and 4 and REM sleep. Comparing the microstructure of sleep (arousals) within episodes with and without ischemia but similar criteria like sleep stage, apnea activity, and oxygen saturation, we found significantly more (p < 0.01) and severe (p < 0.001) arousals during periods with myocardial ischemia than during control episodes. In addition, microstructure of sleep was disturbed by myocardial ischemia itself in absence of apneas.
CONCLUSION: It is concluded that patients with CHD and obstructive sleep apnea are endangered by apnea-associated ischemia and that these ischemic episodes lead to activation of the CNS and additional fragmentation of sleep. Patients with nocturnal ischemia should be screened for underlying sleep apnea even if nitrate therapy fails.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9041987     DOI: 10.1378/chest.111.2.387

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  26 in total

1.  Perioperative practical experiences in using a level 2 portable polysomnography.

Authors:  Frances Chung; Pu Liao; Yuming Sun; Babak Amirshahi; Hoda Fazel; Colin M Shapiro; Hisham Elsaid
Journal:  Sleep Breath       Date:  2010-03-16       Impact factor: 2.816

2.  Sleep apnoea in ischaemic heart disease: differences between acute and chronic coronary syndromes.

Authors:  P Moruzzi; S Sarzi-Braga; M Rossi; M Contini
Journal:  Heart       Date:  1999-09       Impact factor: 5.994

3.  Markers of Myocardial Ischemia in Patients With Coronary Artery Disease and Obstructive Sleep Apnea: Effect of Continuous Positive Airway Pressure Therapy.

Authors:  Misa Valo; Annette Wons; Albert Moeller; Claudius Teupe
Journal:  Clin Cardiol       Date:  2015-07-14       Impact factor: 2.882

4.  Sleep apnea prevalence in acute myocardial infarction--the Sleep Apnea in Post-acute Myocardial Infarction Patients (SAPAMI) Study.

Authors:  Ondrej Ludka; Radka Stepanova; Martina Vyskocilova; Lujza Galkova; Monika Mikolaskova; Milos Belehrad; Jana Kostalova; Zuzana Mihalova; Adela Drozdova; Jiri Hlasensky; Michal Gacik; Lucie Pudilova; Tereza Mikusova; Blanka Fischerova; Fatima Sert-Kuniyoshi; Virend K Somers; Jindrich Spinar; Tomas Kara
Journal:  Int J Cardiol       Date:  2014-06-27       Impact factor: 4.164

5.  Obstructive sleep apnea/hypopnea syndrome and poor response to sertraline in patients with coronary heart disease.

Authors:  Annelieke M Roest; Robert M Carney; Phyllis K Stein; Kenneth E Freedland; Hilary Meyer; Brian C Steinmeyer; Peter de Jonge; Eugene H Rubin
Journal:  J Clin Psychiatry       Date:  2011-08-09       Impact factor: 4.384

6.  Physiological mechanisms of upper airway hypotonia during REM sleep.

Authors:  David G McSharry; Julian P Saboisky; Pam Deyoung; Amy S Jordan; John Trinder; Erik Smales; Lauren Hess; Nancy L Chamberlin; Atul Malhotra
Journal:  Sleep       Date:  2014-03-01       Impact factor: 5.849

7.  Obstructive sleep apnea: no independent association to troponins.

Authors:  Trygve Sørdahl Hall; Tobias Herrscher; Petr Jarolim; Morten W Fagerland; Torstein Jensen; Jonas Hallén; Stefan Agewall; Dan Atar
Journal:  Sleep Breath       Date:  2013-09-17       Impact factor: 2.816

Review 8.  Pathophysiology of sleep apnea.

Authors:  Jerome A Dempsey; Sigrid C Veasey; Barbara J Morgan; Christopher P O'Donnell
Journal:  Physiol Rev       Date:  2010-01       Impact factor: 37.312

9.  Evaluation of the relationship between heart type fatty acid binding protein levels and the risk of cardiac damage in patients with obstructive sleep apnea syndrome.

Authors:  Burcu Oktay; Erdem Akbal; Hikmet Firat; Sadik Ardic; Ramazan Akdemir; Murat Kizilgun
Journal:  Sleep Breath       Date:  2008-01-19       Impact factor: 2.816

10.  Comparison of low resolution electromagnetic tomography imaging between subjects with mild and severe obstructive sleep apnea syndrome: a preliminary study.

Authors:  Hyun-Kwon Lee; Doo-Heum Park; Hyun-Sil Shin; Seok-Chan Hong
Journal:  Psychiatry Investig       Date:  2008-03-31       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.